Cargando…
Immunoexpression of HBME-1, High Molecular Weight Cytokeratin, Cytokeratin 19, Thyroid Transcription Factor-1, and E-cadherin in Thyroid Carcinomas
To examine the immunohistochemical alterations associated with the histological dedifferentiation of thyroid carcinomas, we performed staining for HBME-1, high molecular weight cytokeratin (HCK), CK 19, thyroid transcription factor-1 (TTF-1) and E-cadherin (E-CD) on 125 various types of thyroid carc...
Autores principales: | Choi, Yoon-La, Kim, Mi Kyung, Suh, Jin-Won, Han, Joungho, Kim, Jung Han, Yang, Jung Hyun, Nam, Seok Jin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779285/ https://www.ncbi.nlm.nih.gov/pubmed/16224162 http://dx.doi.org/10.3346/jkms.2005.20.5.853 |
Ejemplares similares
-
E-cadherin and Cytokeratin Subtype Profiling in Effusion Cytology
por: Han, Joungho, et al.
Publicado: (2004) -
CD56, HBME-1 and cytokeratin 19 expressions in papillary thyroid carcinoma and nodular thyroid lesions
por: Erdogan-Durmus, Senay, et al.
Publicado: (2016) -
Diagnostic Value of Galectin-3, HBME-1, Cytokeratin 19, High Molecular Weight Cytokeratin, Cyclin D1 and p27(kip1) in the Differential Diagnosis of Thyroid Nodules
por: Park, Young Joo, et al.
Publicado: (2007) -
Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma
por: Bose, Debdas, et al.
Publicado: (2012) -
An analysis of Cyclin D1, Cytokeratin 5/6 and Cytokeratin 8/18 expression in breast papillomas and papillary carcinomas
por: Wang, Yu, et al.
Publicado: (2013)